The recently published a Research report on Regenerative Medicine Market 2019. This Market research Study gives an in-depth analysis of market Share, Future Growth, and Opportunities. The Research Report gives an Industry Overview, Manufacturing Structure, Technical Data Analysis, Regional Analysis, and Segment Analysis by type and Application.
The Regenerative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.
The Regenerative Medicine market research report shows a comprehensive overview of market size and growth rate of this industry for upcoming years. This research report focuses on the main regions and the main countries (North America, Europe, China, Japan, Southeast Asia and
Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.
On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.
Browse and in-depth TOC on “Regenerative Medicine Market”
76 — Tables
29 — Figures
107 — Pages
Musculoskeletal disorders applications segment likely to dominate the market in 2019.
On the basis of application, the Regenerative Medicine Market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with rising geriatric population.
North America anticipated to account for the largest share of the Regenerative Medicine Market in 2019.
The Regenerative Medicine Market in North America is expected account for the largest share globally, and also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.
The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this Regenerative Medicine Market.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly